Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Boron Neutron Capture Therapy (BNCT) is a cancer treatment modality that utilizes the selective accumulation of the Boron-10 isotope (^{10}B) in tumor cells, mediated by the L-type amino acid transporter 1 (LAT1), followed by irradiation with low-energy thermal neutrons. The neutron capture reaction results in the emission of high-LET alpha particles and lithium nuclei, inducing localized DNA damage and cytotoxicity specifically within tumor cells while sparing surrounding healthy tissue.
Selective accumulation of Boron-10 in tumor cells via LAT1, followed by neutron irradiation that triggers local emission of alpha particles and lithium nuclei, resulting in highly localized ionizing radiation damage to cancer cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Boron Neutron Capture Therapy (BNCT) via LAT1-mediated Boron-10 uptake (BNCT).